BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25957582)

  • 1. Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis.
    Bielecki B; Jatczak-Pawlik I; Wolinski P; Bednarek A; Glabinski A
    Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):367-76. PubMed ID: 25957582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis.
    Alt C; Laschinger M; Engelhardt B
    Eur J Immunol; 2002 Aug; 32(8):2133-44. PubMed ID: 12209625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of chemokine receptors CCR7 and CCR8 in the CNS during ChREAE.
    Bielecki B; Mazurek A; Wolinski P; Glabinski A
    Scand J Immunol; 2007 Oct; 66(4):383-92. PubMed ID: 17850582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation.
    Columba-Cabezas S; Serafini B; Ambrosini E; Aloisi F
    Brain Pathol; 2003 Jan; 13(1):38-51. PubMed ID: 12580544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
    Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
    J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
    Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation.
    Fevang B; Yndestad A; Damås JK; Halvorsen B; Holm AM; Beiske K; Aukrust P; Frøland SS
    Clin Exp Immunol; 2009 Nov; 158(2):237-45. PubMed ID: 19747210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis.
    Oliveira-Neto HH; de Souza PP; da Silva MR; Mendonça EF; Silva TA; Batista AC
    Tumour Biol; 2013 Feb; 34(1):65-70. PubMed ID: 22976543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease.
    Cai W; Tao J; Zhang X; Tian X; Liu T; Feng X; Bai J; Yan C; Han Y
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1933-41. PubMed ID: 24990231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization.
    Damås JK; Smith C; Øie E; Fevang B; Halvorsen B; Waehre T; Boullier A; Breland U; Yndestad A; Ovchinnikova O; Robertson AK; Sandberg WJ; Kjekshus J; Taskén K; Frøland SS; Gullestad L; Hansson GK; Quehenberger O; Aukrust P
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):614-20. PubMed ID: 17170367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
    Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
    J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis.
    Tateyama M; Fujihara K; Misu T; Itoyama Y
    J Neurol Sci; 2009 Apr; 279(1-2):47-52. PubMed ID: 19171354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.
    Hauser MA; Legler DF
    J Leukoc Biol; 2016 Jun; 99(6):869-82. PubMed ID: 26729814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
    Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
    Front Immunol; 2019; 10():2156. PubMed ID: 31572374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis.
    Tateyama M; Fujihara K; Misu T; Feng J; Onodera Y; Itoyama Y
    J Neurol Sci; 2006 Nov; 249(2):158-65. PubMed ID: 16887149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR7-CCL19/CCL21 Axis is Essential for Effective Arteriogenesis in a Murine Model of Hindlimb Ischemia.
    Nossent AY; Bastiaansen AJ; Peters EA; de Vries MR; Aref Z; Welten SM; de Jager SC; van der Pouw Kraan TC; Quax PH
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Important Role of the Chemokine Axis CCR7-CCL19 and CCR7-CCL21 in the Pathophysiology of the Immuno-inflammatory Response in Dry Eye Disease.
    Wang T; Li W; Cheng H; Zhong L; Deng J; Ling S
    Ocul Immunol Inflamm; 2021 Feb; 29(2):266-277. PubMed ID: 31702421
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells.
    Halvorsen B; Dahl TB; Smedbakken LM; Singh A; Michelsen AE; Skjelland M; Krohg-Sørensen K; Russell D; Höpken UE; Lipp M; Damås JK; Holm S; Yndestad A; Biessen EA; Aukrust P
    Cardiovasc Res; 2014 Apr; 102(1):148-56. PubMed ID: 24518141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21.
    Lee J; Park C; Kim HJ; Lee YD; Lee ZH; Song YW; Kim HH
    Exp Mol Med; 2017 Jul; 49(7):e358. PubMed ID: 28729639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACKR4 on Stromal Cells Scavenges CCL19 To Enable CCR7-Dependent Trafficking of APCs from Inflamed Skin to Lymph Nodes.
    Bryce SA; Wilson RA; Tiplady EM; Asquith DL; Bromley SK; Luster AD; Graham GJ; Nibbs RJ
    J Immunol; 2016 Apr; 196(8):3341-53. PubMed ID: 26976955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.